Fremanezumab in Participants With Posttraumatic Headache (PTH)
- Study Title
- A Study to Test if Fremanezumab Reduces Headache in Patients With Posttraumatic Headache (PTH)
- Teva Identifier
- TV48125-CNS-20024
- ClinicalTrials.gov Identifier
- NCT03347188
- Study Status
- Completed
- Trial Condition(s)
- Post-Traumatic Headache
- Interventions
- Drug: Fremanezumab | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 70 Years
- Trial Duration
- November 17, 2017 - June 3, 2020
- Phase
- Phase 2
